Tobe K, et al. - This study explored the effect of sodium glucose co-transporter 2 inhibitor, tofogliflozin on the blood glucose and insulin secretion in patients with high insulin levels. It was concluded that irrespective of the baseline insulin level, tofogliflozin was found to be effective. Nonetheless, it demonstrated the highest efficacy in the H group.